Delivery Order SPE2DB22D1106-SPE2DB25FEHR3
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-320 mg tablets. The $2,856.80 firm-fixed-price contract has an ultimate completion date of August 8, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The contract, valued at $1,323.76, has a firm fixed price pricing type and an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,172.16 contract is for the delivery of Exforge 5-320 mg tablets to support military and government healthcare programs. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,570.80, is a delivery order for Exforge 10-320 mg tablets, with an ultimate completion date of April 10, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The $2,797.79 firm fixed-price contract has a period of performance through February 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,393.26 firm fixed-price delivery order is for the supply of Exforge 10-320 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Exforge 5-320 mg tablets. The contract has a ceiling value of $2,186.96 and runs through January 16, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,743.68 firm fixed-price contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.49 firm-fixed-price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has a ceiling value of $1,126.49 and a period of performance through March 12, 2025. This delivery order is part of a larger Indefinite Delivery...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $6,862.00, is to provide pharmaceutical products including the medication Exforge HCT 5-160-12.5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...